Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease

Nature Medicine

Volumn 4, Issue 4, 1998, Pages 428-434

  Lunardi Iskandar, Yanto ^a   Bryant, Joseph L ^a   Blattner, William A ^a   Hung, Chia Ling ^b   Flamand, Louis ^a,c   Gill, Parkash ^d   Hermans, Philippe ^e   Birken, Steven ^f   Gallo, Robert C ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^f Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CHORIONIC GONADOTROPIN BETA SUBUNIT; CR 127; GAG PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPOSI SARCOMA; MALE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSGENIC MOUSE; URINE; WEIGHT GAIN;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL FACTORS; CELL SURVIVAL; CHORIONIC GONADOTROPIN; DIMERIZATION; FEMALE; GENE DELETION; GENES, GAG; GENES, POL; GENOME, VIRAL; HIV-1; HUMANS; MACACA MULATTA; MALE; MICE; MICE, TRANSGENIC; PREGNANCY; SARCOMA, KAPOSI; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; MUS MUSCULUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0031946661     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0498-428     Document Type: Article

References (23)

1. Lunardi-Iskandar, Y. et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375, 64-68 (1995).
2. Lunardi-Iskandar, Y. et al. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J. Natl. Cancer Inst. 87, 974-981 (1995).
3. Hermans, P. & Clumeck, N. Kaposi's sarcoma in patients infected with human immunodeficiency virus (HIV): an overview. Cell. Mol. Biol. 3, 357-364 (1995).
4. Gill, P. S. et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N. Engl. J. Med. 335, 1261-1269 (1996).
5. Harris, P. J. Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin. The Lancet 346, 118-119 (1995).
6. Gill, P. et al. Phase I study of a preparation of human chorionic gonadotropin given subcutaneously to patients with AIDS-related Kaposi's sarcoma. J. Natl. Cancer Inst. 89, 1797-1802 (1997).
7. Hermans, P. et al. AIDS related Kaposi's sarcoma patients with visceral manifestations: response to human chorionic gonadotropin preparations. J. Human Virol. 1, 82-89 (1998).
8. Letvin, N.L. & King, N.W. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquir. Immune Defic. Syndr. 3, 1023-1040 (1990).
9. Kestler, H. et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248, 1109-1112(1990).
10. Dickie, P. et al. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185, 109-119 (1991).
11. Franks, R. R. et al. Maternal-fetal interactions affect growth of human immunodeficiency virus type 1 transgenic mice. Pediatr. Res. 37, 56-63 (1995).
12. Kopp, J. B. et al. Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. AIDS Res. Hum. Retroviruses 9, 267-275 (1993).
13. Morse, J. H., Lustbader, J.W., Harrington, J.W. & Canfield, R.C. Heterogeneity of proteins in commercial preparations of human chorionic gonadotropin (hCG) demonstrated by Western blotting. Am. J. Reprod. Immunol. Microbiol. 17, 134-140 (1988).
14. Birken, S. et al. Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. Endocrinology 123, 572-583 (1988).
15. Morse, J.H., Stearns G., Arden J., Agosto, G.M. & Canfield, R.E. The effects of crude and purified human gonadotrpin on in vitro stimulated human lymphocyte cultures. Cell. Immunol. 25, 178-188 (1976).
16. Shijirslev, S.V. and Kevorkov, N.N. Relationship between the immunomodulating effects of chorionic gonadotropin and the intense functional activity of the splenocytes mediating the adoptive immune response. Probl. Endokrinal. [Mosk] 39:54-57 (1993).
17. Albini, A. et al. The beta-core fragment of human chorionic gonadotropin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 11 713-721 (1997).
18. Bourinbaiar, A.S. & Lee-Huang, S. Anti-HIV effect of beta subunit of human chorionic gonadotropin (βhCG) in vitro. Immunol. Lett. 44, 13-18 (1995).
19. Swapan, D.E. et al. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice, J. Clin. Invest. 99, 1484-1491 (1997).
20. Griffiths, S.J. Ribonuclease inhibits Kaposi's sarcoma, Nature 390, 568 (1997).
21. Klotman M.E. et al. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. USA 88, 5011-5015 (1991).
22. Popovic, M. et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) form patients with AIDS and pre-AIDS. Science 224, 497-500 (1984).
23. Gallo, R. C. et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503 (1984).